VLVitor Bruno Lourenzon

Vitor Bruno Lourenzon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vitor Bruno Lourenzon has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Monica Tallarico Pupo

    Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo

    3 shared publications
  • Weilan Gomes da Paixão Melo

    Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 14040-903 Ribeirão Preto, SP, Brazil

    3 shared publications
  • Carla Menegatti

    Integrated Discovery and Bioprocess, Crop Health R&D, Corteva Agriscience, 9330 Zionsville Rd, Indianapolis, Indiana 46268, United States

    2 shared publications
  • Adriano D. Andricopulo

    Laboratório de Química Medicinal e Computacional, Centro de Pesquisa e Inovação em Biodiversidade e Fármacos, Instituto de Física de São Carlos, Universidade de São Paulo, Av. João Dagnone 1100, São Carlos-SP 13563-120, Brazil

    1 shared publication
  • Adriano Defini Andricopulo

    Laboratory of Medicinal and Computational Chemistry (LQMC), Centre for Research and Innovation in Biodiversity and Drug Discovery (CIBFar), São Carlos Institute of Physics (IFSC), University of São Paulo (USP), Av. João Dagnone, 1100, São Carlos 13563-120, SP, Brazil

    1 shared publication
  • Alessandra S. Eustaquio

    Department of Pharmaceutical Sciences, Retzky College of Pharmacy, University of Illinois Chicago

    1 shared publication

Latest Publications

  • Open Access

    Pseudovibriamide B from marine sponge-associated bacteria acts as a selective antibiotic antidote

    by Vitor Lourenzon, Yitao Dai, Mandisa Timba, Subhash Yadav, Gabrielle Mingolelli, Matthew Henke, Detmer Sipkema, Alessandra S Eustáquio

    Broad-spectrum antibiotics, while effective against pathogens, can disrupt microbiota leading to dysbiosis. In natural systems, where most antibiotic classes were first identified, some collateral damage control may have evolved as a microbiota protection strategy to the production of broad-spectrum antibiotics. In this work, we investigated whether pseudovibriamide B (PB), a depsipeptide produced by the marine sponge isolated bacterium Pseudovibrio brasiliensis Ab134, can function as a selective antidote to the commercial broad-spectrum antibiotic blasticidin S. An analogue of blasticidin S, named P10, was previously isolated from marine sponges. To improve access to PB and enable testing of the hypothesis, we developed an overexpression strategy targeting core biosynthetic genes, resulting in a more than three-fold increase in PB production. Additionally, we established an assay for antidote testing, the Minimum Antidote Concentration (MAC) assay, which enabled robust identification of antidote activity and quantification of the minimum concentration required to rescue a strain at a given antibiotic dose. The MAC assay revealed that PB selectively protects Bacillus cereus and a marine sponge-associated Bacillus sp., but not pathogens or other sponge-associated isolates, indicating narrow-spectrum antidote activity. These findings support a role of pseudovibriamides as selective antibiotic antagonists and provide a framework for future work of natural antidotes for targeted microbiota protection both in ecological and clinical settings.

  • Antileishmanial macrolides from ant-associated Streptomyces sp. ISID311

    by Humberto E. Ortega, Vitor B. Lourenzon, Marc G. Chevrette, Leonardo L.G. Ferreira, René F. Ramos Alvarenga, Weilan G.P. Melo, Tiago Venâncio, Cameron R. Currie, Adriano D. Andricopulo, Tim S. Bugni, et al.


  • Meliponamycins: Antimicrobials from Stingless Bee-Associated Streptomyces sp.

    by Carla Menegatti, Vitor Bruno Lourenzon, Diego Rodríguez-Hernández, Weilan Gomes da Paixão Melo, Leonardo Luiz Gomes Ferreira, Adriano Defini Andricopulo, Fabio Santos Do Nascimento, Mônica Tallarico Pupo

    Social insects establish complex interactions with microorganisms, some of which play defensive roles in colony protection. The important role of pollinators such as the stingless bee Melipona scutellaris in nature encouraged us to pursue efforts to study its associated microbiota. Here we describe the discovery of two novel cyclic hexadepsipeptides, meliponamycin A (1) and meliponamycin B (2), from Streptomyces sp. ICBG1318 isolated from M. scutellaris nurse bees. Their structures were established by interpretation of NMR and MS data, and the absolute configuration of the constituent amino acids was determined by the advanced Marfey’s method. Compounds 1 and 2 showed strong activity against the entomopathogen Paenibacillus larvae and human pathogens Staphylococcus aureus and Leishmania infantum.


  • Actinobacteria associated with stingless bees biosynthesize bioactive polyketides against bacterial pathogens

    by Diego Rodríguez-Hernández, Weilan G. P. Melo, Carla Menegatti, Vitor B. Lourenzon, Fábio S. Do Nascimento, Mônica T. Pupo

    Social insects can establish nutritional, communication and defensive symbiotic associations with microorganisms, among which actinobacteria play important roles in these symbioses. Stingless bees are characterized by keeping their colonies free of diseases and parasites. These bees have evolved different protective strategies, but most are still unknown. Here we explore the potential of stingless bee Melipona scutellaris to associate with actinobacteria to suppress pathogenic microbes. Seven actinobacterial strains were isolated from foraging and nurse bees and identified through 16S rRNA sequencing. Three of these strains exhibited pronounced growth inhibition against the specialized pathogen of honey bees Paenibacillus larvae, the causative agent of American Foulbrood. Bioassay-guided HPLC fractionation, followed by NMR and mass spectrometry-based structure elucidation, revealed the presence of lobophorin (1–4) and anthracycline (5–15) families isolated from strains Streptomyces sp. ICBG1323 and Micromonospora sp. ICBG1321, all responsible for this activity. Our results suggest that M. scutellaris bees engage in defensive symbiosis with actinobacteria that produce antibacterial small molecules, helping to keep their colonies healthy.